Comparison factors
We are developing displays of comparison criteria and data quantity, including age, sex, underlying conditions, and prior healthcare use.
Hugmedi CARE
In developmentExplore the care journey and its costs.
We are developing care navigation that explains observed journeys and cost ranges, helping patients and families prepare questions about insurance, funds, and payments.
The initial focus is cancer-related care journeys. Data availability and validation determine the target groups and scope. The product is in development.
Illustrative interface · Synthetic data
Explore a synthetic care journey and its costs.
Change the case and follow-up period to view different events and cost distributions. Prepared examples require no personal information.
Hugmedi CAREJOURNEY
Illustrative interface · Synthetic dataAdult in their 50s · prior outpatient use · fictional criteria
Costs over time
Synthetic case 01Selected case · 1-year totalKRW 6,474,000
Total range across 5 synthetic casesKRW 5,411,000— KRW 13,192,000
Monthly totalKRW 3,125,000
Jan 2022Dec 2022
Synthetic medical costs recorded in claims, combining insurer and patient portions. Non-covered care, caregiving, living expenses, and private insurance payments are excluded.
These values are not actual statistics or individual treatment-cost predictions.
Source: fixed synthetic data for interface demonstration. The observation period is fictional.View monthly totals and categories as a table
| Month | Care items | Monthly total (KRW) |
|---|---|---|
| Jan 2022 | Outpatient visit 132,000 / Test 245,000 / Prescription 108,000 / Inpatient care 2,640,000 | 3,125,000 |
| Feb 2022 | Outpatient visit 132,000 / Test 245,000 / Prescription 108,000 | 485,000 |
| Mar 2022 | Outpatient visit 132,000 / Test 245,000 / Prescription 108,000 | 485,000 |
| Apr 2022 | Outpatient visit 132,000 / Test 245,000 / Prescription 108,000 | 485,000 |
| May 2022 | Outpatient visit 132,000 / Test 245,000 / Prescription 108,000 | 485,000 |
| Jun 2022 | Outpatient visit 132,000 / Test 245,000 / Prescription 108,000 | 485,000 |
| Jul 2022 | Outpatient visit 68,000 / Test 166,000 / Prescription 46,000 | 280,000 |
| Aug 2022 | Outpatient visit 68,000 / Prescription 46,000 | 114,000 |
| Sep 2022 | Outpatient visit 68,000 / Prescription 46,000 | 114,000 |
| Oct 2022 | Outpatient visit 68,000 / Test 166,000 | 234,000 |
| Nov 2022 | Outpatient visit 68,000 / Prescription 46,000 | 114,000 |
| Dec 2022 | Outpatient visit 68,000 | 68,000 |
| Period total (KRW) | 6,474,000 | |
Care journey timeline
ChronologicalExpand a month to inspect fictional events and amounts.
Jan 20224 fictional events
- 2022-01-04Outpatient visitKRW 132,000
- 2022-01-07TestKRW 245,000
- 2022-01-10PrescriptionKRW 108,000
- 2022-01-16Inpatient careKRW 2,640,000
Feb 20223 fictional events
- 2022-02-04Outpatient visitKRW 132,000
- 2022-02-07TestKRW 245,000
- 2022-02-10PrescriptionKRW 108,000
Mar 20223 fictional events
- 2022-03-04Outpatient visitKRW 132,000
- 2022-03-07TestKRW 245,000
- 2022-03-10PrescriptionKRW 108,000
Apr 20223 fictional events
- 2022-04-04Outpatient visitKRW 132,000
- 2022-04-07TestKRW 245,000
- 2022-04-10PrescriptionKRW 108,000
QUESTIONS TO PREPARE
From understanding costs to preparing next steps.
Fixed financial-preparation examples. These do not recommend insurance products or determine support eligibility.
Check documents and your payment plan.
- What coverage and claim documents should I check?
- Do payment dates align with available funds?
Capabilities
Check comparison factors and data scope.
We are developing views of groups with comparable age, sex, underlying conditions, and prior healthcare use. Comparison factors and the number of examples are shown together.
Comparable examples
The planned view presents comparable cases where enough data exists. This website provides five fixed synthetic examples.
Care timeline
The timeline organizes observed inpatient care, outpatient visits, tests, prescriptions, and changes of institution over time.
Costs over time
We are developing views of concentrated spending with follow-up periods and included categories shown.
Insufficient data
Observed costs and future personal estimates are distinct. Limitations are identified where comparison data or follow-up is insufficient.
Insurance, funds, and payment preparation
Fixed examples organize questions about insurance timing, available funds, support programs, and hospital payments.
Adoption
Tell us what your patient support team needs to explain.
Discuss the relevant groups, the purpose of the information, and the data your organization can use. Current discussions cover product development and organizational collaboration.
Relevant groups and information needs
Available data and follow-up periods
Included and excluded cost categories
Patient support and consultation procedures
Discuss a CARE partnershipFAQ
Frequently asked questions
Does CARE give an exact personal treatment cost?
No. It explains observed patterns in comparable groups. It does not establish a personal treatment plan or spending amount. Website values are not actual statistics or predictions.
Are displayed costs what a patient pays?
The product direction distinguishes claims costs from insurer and patient portions. Non-covered care, caregiving, living expenses, and private insurance payments require separate information. Displayed amounts do not represent all household spending.
How are sample size and follow-up periods chosen?
The direction considers five or more examples and one to three years of follow-up where data is sufficient. Actual scope depends on quantity, quality, and follow-up availability. Insufficient data is identified separately.
Is CARE available now?
CARE is in development for patients and families. The website currently provides product information and organizational partnership inquiries, rather than individual medical or financial consultations.
Tell us which product or workflow you need.
Get in touchDescribe your current tools and the work you want to improve. We will discuss relevant features and development scope.